Recent Episodes
Insights from Attending the 2022 Society of Hematologic Oncology (SOHO) Annual Meeting
Saad Z. Usmani, MD, MBA, FACP, Memorial Sloan Kettering Cancer Center, New York, NY
What’s New in the Treatment of BPDCN?
Naveen Pemmaraju, MD, The University of Texas MD Anderson Cancer Center, Houston, TX
Mastocytosis: Insight into a Rare Blood Cancer
Jason Gotlib, MD, Stanford University School of Medicine, Palo Alto, CA
The Role of Genomics in Treating Blood Cancers
Rafael Fonseca, MD, Mayo Clinic, Phoenix, AZ
Insights into Pediatric Survivorship for the HCP
Kevin C. Oeffinger, MD, FASCO, Duke University Medical Center, Durham, NC
PedAL: First-of-Its-Kind Global Master Clinical Trial for Pediatric Acute Leukemia
Gwen L. Nichols, MD, The Leukemia & Lymphoma Society, Rye Brook, NY
Categories
- All Episodes (91)
- CAR T-cell Therapy (10)
- Clinical Trials (4)
- COVID-19 (7)
- General Treatment & Support (30)
- Genomics (3)
- Health Equity (7)
- Leukemia (21)
- Lymphoma (12)
- Minimal Residual Disease (MRD) (3)
- Myelodysplastic Syndromes (5)
- Myeloma & Amyloidosis (11)
- Myeloproliferative Neoplasms (3)
- Pediatric and AYA (12)
- Rare Blood Cancers (4)
- Transplantation (4)
- Waldenström macroglobulinemia (2)
